Cite
HARVARD Citation
Shrestha, B. et al. (n.d.). Long‐term survival benefit of upfront chemotherapy in patients with newly diagnosed borderline resectable pancreatic cancer. Cancer medicine. pp. 1552-1562. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Shrestha, B. et al. (n.d.). Long‐term survival benefit of upfront chemotherapy in patients with newly diagnosed borderline resectable pancreatic cancer. Cancer medicine. pp. 1552-1562. [Online].